Graduou-se em medicina pela Faculdade de Medicina da Universidade de São Paulo (FMUSP) em 2001 e realizou residência médica em cirurgia geral (2004) e urologia (2007) no Hospital das Clínicas da FMUSP. Concluiu pós-graduação obtendo o título de doutor em ciências no ano de 2022 pela FMUSP. Atualmente é médico assistente da urologia do Instituto do Câncer do Estado de São Paulo, professor de urologia na Faculdade Santa Marcelina e atua como urologista em seu consultório privado. Foi coordenador da urologia do Centro de Referência da Saúde do Homem por 15 anos e tem experiência na área de urologia com foco na uro-oncologia.
RESEARCH, TEACHING, or OTHER INTERESTS
Urology, Oncology
34
Scopus Publications
1467
Scholar Citations
16
Scholar h-index
22
Scholar i10-index
Scopus Publications
MicroRNAs in penile cancer: challenges, opportunities, and translational perspectives Tatiane Katsue Furuya, Alexis Germán Murillo Carrasco, Miyuki Uno, Gabriela Vitória Penna Arruda, Kayann Kaled Reda El Hayek, Maria José Ferreira Alves, José Pontes Jr, Roger Chammas, Claudio Bovolenta Murta Critical Reviews in Oncology Hematology, 2026 MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression, and dysregulated miRNA expression has been implicated in multiple cancer hallmarks. In penile cancer (PeCa), a rare but aggressive malignancy, evidence suggests that miRNAs contribute to tumor development and disease progression. This review aims to summarize the current understanding of miRNA involvement in PeCa, highlighting their potential as diagnostic, prognostic, and therapeutic biomarkers. A comprehensive review of published studies on miRNA expression in PeCa was performed, with an emphasis on molecular mechanisms, HPV association, clinical outcomes, and recent technological approaches, including high-throughput sequencing and bioinformatics-based analyses. Several miRNAs have been identified as differentially expressed in PeCa, associating with tumor aggressiveness, HPV infection, and patient prognosis. Despite these findings, most studies are descriptive, limited by small cohorts, and lack functional validation. Moreover, geographic disparities have been observed, with a concentration of studies in a few countries and an underrepresentation of high-incidence regions. Advances in omics technologies and the study of novel sources such as extracellular vesicles (EVs) have expanded the potential for identifying circulating miRNAs as non-invasive biomarkers. miRNAs represent promising tools for improving PeCa diagnosis, prognosis, and therapy. However, their clinical translation depends on larger, standardized, and functionally validated studies. In this context, integrating multi-omics and artificial intelligence approaches might accelerate biomarker validation and enable more precise, personalized management of PeCa.
Fourteen-Year Analysis of Percutaneous Nephrolithotripsy Outcomes: Evolution of Technique and Future Perspectives Fábio C. Vicentini, Carlos Batagello, Giovanni Scala Marchini, Fábio César Miranda Torricelli, Artur Henrique Brito, et al. International Braz J Urol, 2026 PURPOSE: The treatment of kidney stones has undergone continuous evolution. Despite the evolution of retrograde intrarenal surgery, percutaneous nephrolithotomy (PNL) remains the gold standard treatment for large and complex stones. We aimed to evaluate and analyze the temporal evolution of the results of the PNLs conducted at two teaching hospitals. RESULTS: Data from 2660 patients were studied between 2009 and 2022. The rate of complex stones (Guy's 3 and 4) was 55.3%. Supine position was used in 82.1% of the cases. In 74.7% of cases, only 1 puncture was performed. The median surgery time was 120 min (15-240 min). The overall complication rate was 12.2%, the transfusion rate was 4.5%, and the success rate was 59.8%. Regarding temporal evolution, the use of the supine position increased from 73% in 2009 to 100% in 2022 (p < 0.001). The use of nephrostomy dropped from 81.8% to 26.5% (p<0.001), the median duration of surgery dropped from 145 to 130 min, the median time of use of fluoroscopy went from 12 to 8 min, the rate of blood transfusions dropped from 11.5% to 2.8% (p= 0.009), and the complication rate dropped from 18.2% to 12% (p= 0.002), while the average length of stay dropped from 81.8 hours to 50 hours. CONCLUSIONS: PNL is an effective surgical option for treating complex kidney stones. The implementation of several technical aspects, along with the standardization of the procedure, led to a significant improvement in most outcomes, reducing complication rates but leaving room for technique improvements in terms of success rates.
Multiparametric MRI combined with PSA density as a noninvasive rule-out strategy in active surveillance for prostate cancer Publio Cesar Cavalcante Viana, Marcelo Araújo Queiroz, Fabio Oliveira Ferreira, Adriano Basso Dias, Natally Horvat, Maurício Dener Cordeiro, Claudio Bovolenta Murta, Giuliano Betoni Guglielmetti, Rafael Ferreira Coelho, Leonardo Cardili, José Pontes, William Carlos Nahas, Giovanni Guido Cerri Bjui Compass, 2025 ObjectiveTo evaluate the diagnostic performance of multiparametric MRI (mpMRI), mpMRI combined with PSA density (PSAd) and combined biopsy (CBx) in detecting clinically significant prostate cancer (csPCa) in men undergoing active surveillance, using radical prostatectomy (RP) specimens as the reference standard.Patients and MethodsIn this prospective single‐centre study, 91 patients with low‐risk prostate cancer under active surveillance underwent mpMRI, PSAd measurement, CBx and ultimately RP. mpMRI was reported using PI‐RADS v2.0, and PSAd was dichotomised at 0.12 ng/ml/cm3. Diagnostic accuracy was compared using ISUP grade ≥2 and ≥3 thresholds. Radical prostatectomy pathology served as the reference standard.ResultsFor detecting ISUP ≥3 cancer, mpMRI combined with PSAd achieved the highest sensitivity (93.3%) and negative predictive value (94.4%). CBx demonstrated the highest specificity (88.2%) and overall diagnostic balance (Youden index = 0.348). mpMRI alone showed intermediate performance. Differences in classification between strategies were statistically significant (McNemar p < 0.001).ConclusionsmpMRI combined with PSAd provides high sensitivity and negative predictive value for ruling out aggressive prostate cancer, supporting its use as a non‐invasive triage tool in active surveillance. CBx remains the most specific method for histological confirmation. These strategies should be used complementarily to optimise decision‐making in active surveillance protocols.
ERG and PTEN Role on Active Surveillance for Low-Risk Prostate Cancer in the Multiparametric MRI Era Marco Aurelio Watanabe Yorioka, Claudio Bovolenta Murta, Kátia Ramos Moreira Leite, Leonardo Cardili, Evandro Sobroza de Mello, Arnaldo Jose de Carvalho Fazoli, Maurício Dener Cordeiro, Rafael Ferreira Coelho, Públio Cesar Cavalcante Viana, Cesar Sadao Nicolino Kohama, William Carlos Nahas, José Pontes‐Júnior Prostate, 2025 BackgroundOur study aimed to correlate ERG and PTEN expressions in prostate biopsy with multiparametric magnetic resonance imaging PI‐RADS score, clinical reclassification, and prognosis of very low‐risk prostate cancer (PCa) patients under active surveillance (AS).MethodsWe evaluated 101 very low‐risk PCa patients under AS between 2013 and 2018. They were followed with DRE, PSA, MRI, and re‐biopsies every 1–2 years. Per cause biopsy was recommended if PSA > 10 ng/mL, suspicious DRE, or PI‐RADS ≥ 4 was present. ERG and PTEN expressions were assessed by immunohistochemistry at biopsy. Reclassification was defined by PSA > 10 ng/mL, re‐biopsy with > 3 positive cores, > 50% positive core, Gleason Score (GS) upgrading ≥ 3 + 4 or extreme GS upgrading ≥ 4 + 3. We correlated ERG and PTEN with reclassification, PI‐RADS, pathologic outcomes, and biochemical recurrence in patients surgically treated after reclassification.ResultsAfter a 49.2‐month follow‐up, 80% of patients showed reclassification, and GS upgrading was the most common criterion. Seventy‐four out of 81 patients with reclassification underwent local treatment and seven had biochemical recurrence during a mean 39.7‐month follow‐up. At biopsy, positive ERG expression was found in 39.6% of patients and PTEN loss in 12.6%. PTEN loss was associated with GS upgrading (OR = 9.7, p = 0.011) in univariate analysis. PTEN loss was correlated with GS upgrading; these patients had a 9.7‐fold greater chance of upgrading when compared to PTEN‐positive patients. ERG‐positive was associated with PI‐RADS ≥ 4 (OR = 2.8, p = 0.026). At multivariate analysis, PI‐RADS ≥ 4 was predictor of GS upgrading (OR = 25.2, p < 0.001); MRI PI‐RADS score remained an independent factor for extreme GS upgrading, together with PSAd > 0.15 (OR = 15.1, p = 0.012 and OR = 5.76, p = 0.012, respectively).ConclusionsNeither ERG‐positive nor PTEN loss were associated with upgrading during AS. ERG and PTEN biomarkers, despite commonly studied in advanced PCa, have yet no defined role in very low‐risk PCa under AS. PI‐RADS score was an independent predictor of GS upgrading and extreme upgrading during AS.
Prostate cancer focal therapy: surgeon experience influences oncological results Claudio Bovolenta Murta, José Pontes Júnior, Pedro Humberto Felix de Souza Filho, Paulo Cezar de Godoy Júnior, Felipe Guimarães Pugliesi, Kayann Reda El Hayek, Fábio Pescarmona Gallucci, Giuliano Betoni Guglielmetti, Joaquim Francisco de Almeida Claro Prostate, 2025 IntroductionCharacterization of the index lesion of prostate cancer (PCa) has facilitated the development of focal therapy to reduce complications caused by radical treatments. In the present study, we sought to identify factors associated with the oncological results of focal therapy for PCa.MethodsBetween April 2017 and February 2020, 123 PCa patients received focal therapy performed with high‐intensity focused ultrasound (HIFU). The patients presented unilateral localized disease, PSA < 20 ng/dl, clinical stage T1–T2, ISUP grade 1–3, and more than 10 years of life expectancy. Five certified surgeons with different levels of experience performed the procedures and were divided into groups #1 and #2 (>30 HIFUs performed) and #3 (10–15 HIFUs performed each). All patients were prospectively followed and underwent surveillance biopsy 1 year post‐treatment. The primary endpoint was radical treatment, and secondary endpoints included focal therapy failure and in‐field recurrence. Univariate and multivariate logistic regression were used to detect associations between clinical and procedure variables and the endpoints.ResultsThe median follow‐up was 54.3 months, with a mean age of 64.4 years. The mean PSA was 6.6 ng/dl; 59.3% of patients had intermediate‐risk disease, and the remaining had low‐risk. During follow‐up, 29 (23.6%) patients required radical treatment (external beam radiation therapy), 37 (30.1%) experienced treatment failure, and 26 (21.1%) had an in‐field recurrence with an ISUP grade of ≥2. Radical treatment in the follow‐up was associated with patients treated by surgeons in group #3 and with elevated post‐HIFU PSA concentrations. Baseline PSA concentrations, group #3 surgeons, and post‐HIFU PSA concentrations were associated with treatment failure. In‐field positive biopsies were associated with baseline and post‐HIFU PSA concentrations. Furthermore, patients treated by surgeons in group #3 were independently associated with radical treatment and focal therapy failure.ConclusionFocal therapy with HIFU has acceptable oncological outcomes in the medium term, and the surgeon's experience and technique are independently associated with the need for subsequent radical treatment and focal therapy failure.
Are very thin patients at a higher risk of complications when submitted to percutaneous nephrolithotomy? Priscila Kuriki Vieira Mota, Daniel Beltrame Ferreira, Rafael Felisberto Dias Florencio, David Jacques Cohen, Rodrigo Perrella, Carlos Alfredo Batagello, Claudio Bovolenta Murta, Joaquim Francisco de Almeida Claro, Fabio C. Vicentini International Braz J Urol, 2024 PURPOSE: To assess the impact of thinness on the outcome of the percutaneous nephrolithotomy (PCNL). MATERIALS AND METHODS: A matched case-control study was performed using a prospectively collected database of all patients who underwent PCNL between June 2011 and October 2021. The patients were stratified into two groups according to their phenotypic characteristics, arbitrarily defined according to their body mass index (BMI): <0kg/m2 (Group 1, very thin patients, G<20) and ≥25 kg/m2 (Group 2, non-thin patients, G≥25). Patients were randomly matched based on Guy's Stone Score (GSS) according to case complexity at a ratio of 1:3. RESULTS: A total of 204 patients were enrolled in this study: 51 patients (G<20) and 153 controls (G≥25). Complications occurred in 15.2% of the patients, with 5.4% of these complications classified as major complications (Clavien grade ≥ 3). According to complications there were no significant differences between the groups. The overall complication rates were 17.6% in the G<20 and 14.4% in the G≥25 (p = 0.653). The major complication rates were 3.9% in the G<20 and 5.8% in the G≥25 (p=0.429). No differences in transfusion or urinary fistula rates were found. CONCLUSIONS: In this study, very thin patients were not at a higher risk of complications when submitted to PCNL than in those with a BMI of ≥25 kg/m2. Apparently, this technique can be used in these patients, just as it is used in any other type of patient, independently of their BMI.
Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial William Carlos Nahas, Gilberto José Rodrigues, Fabio Augusto Rodrigues Gonçalves, Guilherme Vinícius Sawczyn, Guilherme Garcia Barros, Leonardo Cardili, Giuliano Betoni Guglielmetti, Arnaldo José De Carvalho Fazoli, Maurício Dener Cordeiro, Valter Dell Acqua Cassão, Daher Cesar Chade, Luiz Carlos Neves De Oliveira, Cláudio Bovolenta Murta, José Pontes Júnior, Evelinda Marramon Trindade, Diogo Assed Bastos, Alvaro Sadek Sarkis, Anuar Ibrahim Mitre, Quoc-Dien Trinh, Rafael Ferreira Coelho Journal of Urology, 2024 PURPOSE: Limited high-quality studies have compared robot-assisted laparoscopic prostatectomy (RALP) vs open retropubic radical prostatectomy. We sought to compare their postoperative outcomes in a randomized setting. MATERIALS AND METHODS: In a single center, 354 men with newly diagnosed prostate cancer were assessed for eligibility; 342 were randomized (1:1). The primary outcome was 90-day complication rates. Functional outcomes and quality of life were assessed over 18 months, and oncological outcomes, biochemical recurrence-free survival, and additional treatment over 36 months. RESULTS: < .001). Quality of life over the 18 months and oncological outcomes over 36 months were not significantly different between arms. CONCLUSIONS: Complications at 90 days were similar. RALP showed superior sexual outcomes at 1 year, improved urinary outcomes at 18 months, and comparable oncological outcomes at 36 months. TRIAL REGISTRATION: Prospective Analysis of Robot-Assisted Surgery; NCT02292914. https://clinicaltrials.gov/ct2/show/NCT02292914?cond=NCT02292914&draw=2&rank=1.
Increased risk of bladder cancer recurrence due to bacillus Calmette-Guérin shortage in Brazil Claudio Bovolenta Murta, Kayann Kaled Reda El Hayek, Bruno Cesar Dias, Marco Aurélio Watanabe Yorioka, Valter DellAcqua Cassao, Joaquim Francisco de Almeida Claro Revista Da Associacao Medica Brasileira, 2024 OBJECTIVE: Our study aimed to evaluate the impact of bacillus Calmette-Guérin shortage on recurrence and progression in patients with non-muscle invasive bladder cancer in a Brazilian cohort. METHODS: We retrospectively reviewed the clinicopathological data of 409 patients who had their first transurethral resection of the bladder tumor for intermediate or high-risk non-muscle invasive bladder cancer between June 2014 and May 2021 in a tertiary public hospital in Brazil. Patients included had non-muscle-invasive urothelial carcinoma of the bladder resected completely for the first time, regardless of bacillus Calmette-Guérin use. Low-risk disease patients were excluded from the analysis. Demographic, clinicopathological, and bacillus Calmette-Guérin use data were collected from our database. Recurrence and progression data were obtained from patient records or through telephone interviews. Recurrence-free survival and progression-free survival were calculated from the date of transurethral resection of the bladder tumor until the events of recurrence, progression, last office visit, or phone interview. RESULTS: Within a median follow-up period of 26.7 months, 168 (41.1%) patients experienced a recurrence in a median time of 27 months (95%CI 16.1-38). Bacillus Calmette-Guérin was administered to 57 (13.9%) individuals after transurethral resection of the bladder tumor. Patients with ≥3 lesions (p<0.001), those with lesions >3 cm (p=0.02), and those without bacillus Calmette-Guérin treatment (p<0.001) had shorter recurrence-free survival. According to a Cox multivariate regression model, bacillus Calmette-Guérin use was independently associated with a reduced recurrence rate, with an HR of 0.43 (95%CI 0.25-0.72). Out of the patients studied, 26 (6.4%) experienced progression. T1 stage (p<0.001) and high-grade (p<0.001) were associated with shorter progression-free survival. Bacillus Calmette-Guérin did not influence bladder cancer progression. In the Cox multivariate analysis, high-risk disease was independently associated with progression (p<0.001). CONCLUSION: Our study confirms that non-muscle invasive bladder cancer exhibits a high recurrence rate. The use of adjuvant bacillus Calmette-Guérin in intermediate and high-risk patients significantly reduces this rate. Furthermore, the bacillus Calmette-Guérin shortage could have negatively impacted these patients.
Factors associated with complications after percutaneous nephrolithotomy: an analysis of 1,066 cases Danniel Frade Said, Daniel Beltrame Ferreira, Kayann Kaled Reda El Hayek, Rodrigo Perrella, Priscila Kuriki Vieira Mota, David Jacques Cohen, Carlos Alfredo Batagello, Claudio Bovolenta Murta, Joaquim Francisco de A. Claro, Fabio Carvalho Vicentini Revista Da Associacao Medica Brasileira, 2023 OBJECTIVE: The aim of this study was to identify predictive factors for complications after percutaneous nephrolithotomy. METHODS: We prospectively analyzed patients who underwent percutaneous nephrolithotomy from June 2011 to October 2018. The association of preoperative and intraoperative factors with the presence of complications was assessed using univariate and multivariate analyses. The significance level was set at p<0.05. RESULTS: A total of 1,066 surgeries were evaluated, and the overall complication rate was 14.9%. In all, 105 (9.8%) surgeries were performed in the prone position, and 961 (90.2%) were performed in the supine position. Univariate analysis demonstrated that surgical position, upper pole puncture, surgical time, number of tracts, and Guys Stone Score were associated with complications. In multivariate analyses, prone position (odds ratio [OR] 2.10; p=0.003), surgical time ≥90 min (OR 1.76; p=0.014), upper pole puncture (OR 2.48; p<0.001), and Guys Stone Score 3 or 4 (OR 1.90; p=0.033) were independent predictive factors for complications after percutaneous nephrolithotomy. CONCLUSION: Performing percutaneous nephrolithotomy in the supine position, in under 90 min, and avoiding upper pole punctures may reduce complications during the treatment of large kidney stones.
Supine versus Prone Percutaneous Nephrolithotomy for Complex Stones: A Multicenter Randomized Controlled Trial Rodrigo Perrella, Fabio C. Vicentini, Eliane D. Paro, Fabio C. M. Torricelli, Giovani S. Marchini, Alexandre Danilovic, Carlos A. Batagello, Priscila K. V. Mota, Daniel B. Ferreira, David J. Cohen, Claudio B. Murta, Joaquim F. A. Claro, Guido Giusti, Manoj Monga, William C. Nahas, Miguel Srougi, Eduardo Mazzucchi Journal of Urology, 2022
Reply by Authors Rodrigo Perrella, Fabio C. Vicentini, Eliane D. Paro, Fabio C. M. Torricelli, Giovani S. Marchini, Alexandre Danilovic, Carlos A. Batagello, Priscila K. V. Mota, Daniel B. Ferreira, David J. Cohen, Claudio B. Murta, Joaquim F. A. Claro, Guido Giusti, Manoj Monga, William C. Nahas, Miguel Srougi, Eduardo Mazzucchi Journal of Urology, 2022
Impact of Obesity on Outcomes of Supine Percutaneous Nephrolithotomy Thiago Augusto Cunha Ferreira, Matheus Marques Guerra Dutra, Fabio Carvalho Vicentini, Marcelo Szwarc, Priscila Kuriki Vieira Mota, Brian Eisner, Claudio Bovolenta Murta, Joaquim Francisco de Almeida Claro Journal of Endourology, 2020
Single port transvesical prostatectomy. Fabio C. Vicentini, Marcelo Hisano, Tulio S. Agresta, Claudio B. Murta, Joaquim F. A. Claro International Braz J Urol Official Journal of the Brazilian Society of Urology, 2012
IP13-01 LIQUID BIOPSY USING NEXT-GENERATION SEQUENCING TO PREDICT LYMPH NODE METASTASES IN PENILE SQUAMOUS CELL CARCINOMA LM Fonseca, KRM Leite, STR Faria, JPL Silva, CB Murta, G Padovani, ... Journal of Urology 215 (5S), e290 , 2026 2026
MicroRNAs in penile cancer: challenges, opportunities, and translational perspectives TK Furuya, AGM Carrasco, M Uno, GVP Arruda, KKR El Hayek, MJF Alves, ... Critical reviews in oncology/hematology, 105274 , 2026 2026 Citations: 1
Fourteen-Year Analysis of Percutaneous Nephrolithotripsy Outcomes: Evolution of Technique and Future Perspectives FC Vicentini, CA Batagello, GS Marchini, FCM Torricelli, A Brito, ... International braz j urol 52 (1), e20250403 , 2026 2026
Multiparametric MRI combined with PSA density as a noninvasive rule‐out strategy in active surveillance for prostate cancer PCC Viana, MA Queiroz, FO Ferreira, AB Dias, N Horvat, MD Cordeiro, ... BJUI compass 6 (9), e70079 , 2025 2025 Citations: 2
ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era MAW Yorioka, CB Murta, KRM Leite, L Cardili, ES de Mello, ... The Prostate 85 (4), 364-373 , 2025 2025 Citations: 4
Prostate cancer focal therapy: surgeon experience influences oncological results CB Murta, JP Júnior, PHF de Souza Filho, PC de Godoy Júnior, ... The Prostate 85 (1), 58-64 , 2025 2025 Citations: 1
Are very thin patients at a higher risk of complications when submitted to percutaneous nephrolithotomy? PKV Mota, DB Ferreira, RFD Florencio, DJ Cohen, R Perrella, ... International braz j urol 50 (6), 746-753 , 2024 2024 Citations: 2
Perioperative, oncological, and functional outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy: a randomized clinical trial WC Nahas, GJ Rodrigues, FA Rodrigues Gonçalves, GV Sawczyn, ... The Journal of urology 212 (1), 32-40 , 2024 2024 Citations: 61
Increased risk of bladder cancer recurrence due to bacillus Calmette-Guérin shortage in Brazil CB Murta, KKRE Hayek, BC Dias, MAW Yorioka, VDA Cassao, JFA Claro Revista da Associação Médica Brasileira 70 (5), e20231116 , 2024 2024 Citations: 3
MP41-10 ERG AND PTEN ROLE ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA MA Watanabe Yorioka, CB Murta, L Cardili, PC Cavalcante Viana, ... The Journal of Urology 211 (5S), e677 , 2024 2024
ERGAND PTEN ROLEONACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IN THE MULTIPARAMETRIC MRI ERA MAW YORIOKA, CB MURTA, L CARDILI, PCC VIANA, KRM LEITE, ... LIPPINCOTT WILLIAMS & WILKINS , 2024 2024
Perioperative morbidity of radical prostatectomy after intensive neoadjuvant androgen blockade in men with high-risk prostate cancer: results of phase II trial compared to a … EN Ilario, DA Bastos, GB Guglielmetti, CB Murta, L Cardili, MD Cordeiro, ... Clinical genitourinary cancer 21 (1), 43-54 , 2023 2023 Citations: 11
Factors associated with complications after percutaneous nephrolithotomy: an analysis of 1,066 cases DF Said, DB Ferreira, KKRE Hayek, R Perrella, PKV Mota, DJ Cohen, ... Revista da Associação Médica Brasileira 69, e20221089 , 2023 2023 Citations: 12
Effectiveness of intrarectal povidone-iodine cleansing plus formalin disinfection of the needle tip in decreasing infectious complications after transrectal prostate biopsy: a … J Pontes-Junior, TM Freire, FG Pugliesi, FM de Moura Costa, ... The Journal of urology 208 (6), 1194-1202 , 2022 2022 Citations: 20
Ultrasound guided endoscopic combined Intrarenal surgery–10 steps for the success FC Vicentini, KKRE Hayek, M Szwarc, R Perrella, P Kuriki, D Cohen, ... International braz j urol 48 (5), 874-875 , 2022 2022 Citations: 3
Holmium laser resection of large bladder tumors: technique description, feasibility, and histopathological quality analysis A Iscaife, LA Ribeiro Filho, MWA Pereira, FP Gallucci, D Chade, CB Murta, ... Urology 165, 373 , 2022 2022 Citations: 12
miRNA and mRNA expression profiles associated with lymph node metastasis and prognosis in penile carcinoma CB Murta, TK Furuya, AGM Carrasco, M Uno, L Sichero, LL Villa, SF Faraj, ... International Journal of Molecular Sciences 23 (13), 7103 , 2022 2022 Citations: 10
Predictive factors for success after supine percutaneous nephrolithotomy: an analysis of 961 patients KKR El Hayek, R Perrella, DB Ferreira, CA Batagello, PKV Mota, ... Revista da Associação Médica Brasileira 68 (06), 780-784 , 2022 2022 Citations: 2
Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic … DA Bastos, R Coelho, L Cardili, F Galiza, EN Ilario, P Viana, CB Murta, ... Journal of Clinical Oncology 40 (16_suppl), 5085-5085 , 2022 2022 Citations: 7
Supine versus prone percutaneous nephrolithotomy for complex stones: a multicenter randomized controlled trial R Perrella, FC Vicentini, ED Paro, FCM Torricelli, GS Marchini, ... The Journal of urology 207 (3), 647-656 , 2022 2022 Citations: 47
MOST CITED SCHOLAR PUBLICATIONS
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study R Ilić Anaesthesia , 2021 2021 Citations: 675
SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 77 (1), 28-39 , 2022 2022 Citations: 72
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study GS Collaborative, COVIDSurg Collaborative The British journal of surgery 108 (9), 1056 , 2021 2021 Citations: 71
Evaluation of the incidence of bladder perforation after transurethral bladder tumor resection in a residency setting OR El Hayek, RF Coelho, MF Dall'oglio, CB Murta, LAR Filho, RLV Nunes, ... Journal of endourology 23 (7), 1183-1186 , 2009 2009 Citations: 68
Perioperative, oncological, and functional outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy: a randomized clinical trial WC Nahas, GJ Rodrigues, FA Rodrigues Gonçalves, GV Sawczyn, ... The Journal of urology 212 (1), 32-40 , 2024 2024 Citations: 61
Modified complete supine percutaneous nephrolithotomy: solving some problems FC Vicentini, FCM Torricelli, E Mazzucchi, M Hisano, CB Murta, ... Journal of endourology 27 (7), 845-849 , 2013 2013 Citations: 54
Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464 , 2021 2021 Citations: 51
Comparative study of percutaneous nephrolithotomy performed in the traditional prone position and in three different supine positions PAS Melo, FC Vicentini, R Perrella, CB Murta, JFA Claro International braz j urol 45 (1), 108-117 , 2019 2019 Citations: 48
Supine versus prone percutaneous nephrolithotomy for complex stones: a multicenter randomized controlled trial R Perrella, FC Vicentini, ED Paro, FCM Torricelli, GS Marchini, ... The Journal of urology 207 (3), 647-656 , 2022 2022 Citations: 47
Intravenous misplacement of the nephrostomy catheter following percutaneous nephrostolithotomy: two case reports E Mazzucchi, A Mitre, A Brito, M Arap, C Murta, M Srougi Clinics 64 (1), 69-70 , 2009 2009 Citations: 38
Outcomes of more than 1 000 percutaneous nephrolithotomies and validation of Guy's stone score PA de Souza Melo, FC Vicentini, AA Beraldi, M Hisano, CB Murta, ... BJU international 121 (4), 640-646 , 2018 2018 Citations: 37
Patients with encrusted ureteral stents can be treated by a single session combined endourological approach RI Lopes, R Perrella, CH Watanabe, F Beltrame, A Danilovic, CB Murta, ... International braz j urol 47, 574-583 , 2021 2021 Citations: 24
Impact of obesity on outcomes of supine percutaneous nephrolithotomy TAC Ferreira, MMG Dutra, FC Vicentini, M Szwarc, PKV Mota, B Eisner, ... Journal of Endourology 34 (12), 1219-1222 , 2020 2020 Citations: 22
Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma CB Murta, AA Antunes, MF Dall'Oglio, A Mosconi, KR Leite, M Srougi Clinics 63, 223-228 , 2008 2008 Citations: 22
Effectiveness of intrarectal povidone-iodine cleansing plus formalin disinfection of the needle tip in decreasing infectious complications after transrectal prostate biopsy: a … J Pontes-Junior, TM Freire, FG Pugliesi, FM de Moura Costa, ... The Journal of urology 208 (6), 1194-1202 , 2022 2022 Citations: 20
Impact of patient position on the outcomes of percutaneous neprolithotomy for complex kidney stones FC Vicentini, R Perrella, VMG Souza, M Hisano, CB Murta, JFA Claro International braz j urol 44 (5), 965-971 , 2018 2018 Citations: 19
Factors associated with complications after percutaneous nephrolithotomy: an analysis of 1,066 cases DF Said, DB Ferreira, KKRE Hayek, R Perrella, PKV Mota, DJ Cohen, ... Revista da Associação Médica Brasileira 69, e20221089 , 2023 2023 Citations: 12
Holmium laser resection of large bladder tumors: technique description, feasibility, and histopathological quality analysis A Iscaife, LA Ribeiro Filho, MWA Pereira, FP Gallucci, D Chade, CB Murta, ... Urology 165, 373 , 2022 2022 Citations: 12
Disruption of miRNA-mRNA networks defines novel molecular signatures for penile carcinogenesis TK Furuya, CB Murta, AG Murillo Carrasco, M Uno, L Sichero, LL Villa, ... Cancers 13 (19), 4745 , 2021 2021 Citations: 12
Perioperative morbidity of radical prostatectomy after intensive neoadjuvant androgen blockade in men with high-risk prostate cancer: results of phase II trial compared to a … EN Ilario, DA Bastos, GB Guglielmetti, CB Murta, L Cardili, MD Cordeiro, ... Clinical genitourinary cancer 21 (1), 43-54 , 2023 2023 Citations: 11
